This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07525/identifier/pdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB07525/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07525/identifier/pubchem-substance/
n7http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB07525/identifier/drugbank/
admshttp://www.w3.org/ns/adms#
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07525/identifier/chemspider/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB07525
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n7:DB07525 n14:DB07525
dcterms:title
3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine
adms:identifier
n9:99443996 n10:C4F n11:24180722 n12:22376728 n13:DB07525
n3:IUPAC-Name
n4:271B4CDA-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4CE0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4CDF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4CDC-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4CDD-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4CDE-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4CD8-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4CD6-363D-11E5-9242-09173F13E4C5 n4:271B4CD9-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4CD7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4CE6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4CE7-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4CE1-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4CE2-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4CE4-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4CE3-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4CE5-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4CEC-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4CEE-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4CEF-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4CEB-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4CEA-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4CED-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4CDB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4CE8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4CE9-363D-11E5-9242-09173F13E4C5